Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Mimi"

35 News Found

Artificial retinal device mimics human optical illusions: WPI-MANA
Biotech | March 10, 2022

Artificial retinal device mimics human optical illusions: WPI-MANA

The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte


Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Clinical Trials | April 30, 2026

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026


Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action
Supply Chain | April 30, 2026

Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action

Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies


New support group targets delayed diagnosis of Vasculitis in India
Healthcare | April 20, 2026

New support group targets delayed diagnosis of Vasculitis in India

Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide


NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering
R&D | April 20, 2026

NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering

The innovation is particularly suited for bone and cartilage repair


The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave
Healthcare | April 07, 2026

The Semaglutide Surge: How a diabetes therapy sparked India’s weight loss wave

As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact


Syntis Bio launches first patient dosing for groundbreaking oral obesity therapy
Clinical Trials | March 05, 2026

Syntis Bio launches first patient dosing for groundbreaking oral obesity therapy

SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum


FDA finds no clear link between popular diabetes, weight-loss drugs and suicidal thoughts
News | January 16, 2026

FDA finds no clear link between popular diabetes, weight-loss drugs and suicidal thoughts

The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts


Cipla launches needle-free inhalable insulin Afrezza in India
News | December 26, 2025

Cipla launches needle-free inhalable insulin Afrezza in India

Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge


Thyrocare launches comprehensive GLP-1 health check across India
Healthcare | November 21, 2025

Thyrocare launches comprehensive GLP-1 health check across India

Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion